CPG
ABBV icon

Custom Portfolio Group’s AbbVie ABBV Stock Holding History

Custom Portfolio Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$329K Hold
2,418
– – 0.26% 37
2024
Q1 		$349K Hold
2,418
– – 0.29% 33
2023
Q4 		$297K Buy
+2,418
New +$353K 0.26% 32

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Custom Portfolio Group's ABBV Position: Q2 2024 in Review

Custom Portfolio Group held its AbbVie (ABBV) position steady in Q2 2024 at 2,418 shares worth $329K. The position accounts for 0.26% of the portfolio, ranked #37.

Custom Portfolio Group first reported a position in ABBV in Q4 2023 and has held it in 3 quarters since. The position peaked at $349K in Q1 2024. 3,370 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.

  • Custom Portfolio Group held 2,418 shares of AbbVie worth $329K as of Q2 2024.
  • Custom Portfolio Group left its AbbVie share count unchanged in Q2 2024.
  • AbbVie made up 0.26% of Custom Portfolio Group's portfolio in Q2 2024, its #37 holding.
  • Custom Portfolio Group first reported a position in AbbVie in Q4 2023 and has held it in 3 quarters since.
  • Custom Portfolio Group's AbbVie position peaked at $349K in Q1 2024.
  • 3,370 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.

Based on Custom Portfolio Group's 13F filing for Q2 2024, filed 27 Aug 2024.